EUVIMEDEUVIMED entdecken
Open Access

Cognitive trajectories diverge by genetic risk in a preclinical longitudinal cohort

Eva Vasiljevic iD, Rebecca Langhough Koscik, Erin Jonaitis, Tobey Betthauser, Sterling C Johnson, Corinne D Engelman

Alzheimer's & Dementia · 2023-07 · 19 (7) · 3108-3118

DOI: 10.1002/alz.12920 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2023-02. Verfasst von Eva Vasiljevic und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NCATS NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION We sought to characterize the timing of changes in cognitive trajectories related to genetic risk using the apolipoprotein E ( APOE ) score, a continuous measure of Alzheimer's disease (AD) risk. We also aimed to determine whether that timing was different when genetic risk was measured using an AD polygenic risk score (PRS) that contains APOE . METHODS We analyzed trajectories ( N ≈1135) for four neuropsychological composite scores using mixed effects regression for longitudinal change across APOE scores and PRS of participants in the Wisconsin Registry for Alzheimer's Prevention, a longitudinal study of adults aged 40 to 70 at baseline, with a median participant follow‐up time of 7.8 years. RESULTS We found a significant non‐linear age‐by‐ APOE score interaction in predicting cognitive decline. Cognitive trajectories diverged by APOE score at approximately 65 years of age. A 0.5 standard deviation difference in cognition between extreme percentiles of the PRS was predicted to occur 1 to 2 years before that of the APOE score. DISCUSSION Cognitive decline differs across time and APOE score. Estimates did not substantially shift with the AD PRS. Highlights The apolipoprotein E ( APOE ) score, a continuous measure, accounts for non‐linear genetic risk of Alzheimer's disease. Non‐linear age interacts with the APOE score to affect cognition. Cognitive decline starts to differ by APOE score levels at approximately age 65. Cognitive decline timing by polygenic risk (including APOE ) is similar to APOE alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCognitive DysfunctionAdultHumansAgedLongitudinal StudiesNeuropsychological TestsCognitionApolipoproteins ERisk FactorsApolipoprotein E4

Stichwörter der Autor:innen

APOEAlzheimer's diseasePGSPRSageapolipoprotein Ecognitioncognitive declinegeneticslongitudinalpolygenic risk score

Substanzen

Apolipoproteins EApolipoprotein E4

Autor:innen und Institutionen

  • Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
  • Center for Demography of Health and Aging, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Wisconsin Alzheimer's Institute, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
  • Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
  • Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Geriatric Research Education and Clinical Center, William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin, USA.

ORCID-Profile: Eva Vasiljevic

Förderung

  • NIA NIH HHS
  • NCATS NIH HHS
  • NICHD NIH HHS
  • National Institute on Aging
  • National Center for Advancing Translational Sciences
  • University of Wisconsin-Madison

Zitieren

APA

Vasiljevic, E., Koscik, R. L., Jonaitis, E., Betthauser, T., Johnson, S. C., & Engelman, C. D. (2023). Cognitive trajectories diverge by genetic risk in a preclinical longitudinal cohort. Alzheimer's & Dementia, 19(7), 3108-3118. https://doi.org/10.1002/alz.12920

Vancouver

Vasiljevic E, Koscik RL, Jonaitis E, Betthauser T, Johnson SC, Engelman CD. Cognitive trajectories diverge by genetic risk in a preclinical longitudinal cohort. Alzheimer's & Dementia. 2023;19(7):3108-3118. doi:10.1002/alz.12920

BibTeX
@article{Vasiljevic2023,
  author = {Vasiljevic, Eva and Koscik, Rebecca Langhough and Jonaitis, Erin and Betthauser, Tobey and Johnson, Sterling C and Engelman, Corinne D},
  title = {Cognitive trajectories diverge by genetic risk in a preclinical longitudinal cohort},
  journal = {Alzheimer's & Dementia},
  year = {2023},
  volume = {19},
  number = {7},
  pages = {3108--3118},
  doi = {10.1002/alz.12920}
}
Kostenlos starten →